Araştırma Makalesi
BibTex RIS Kaynak Göster
Yıl 2005, Cilt: 7 Sayı: 1, 0 - 0, 01.01.2005
https://doi.org/10.1501/Ashd_0000000057

Öz

Kaynakça

  • Ankara Üniversitesi – Ankara Sağlık Hizmetleri Dergisi - ASHD

Hyperfractionated Radiotherapy in Malignant Astrocytomas

Yıl 2005, Cilt: 7 Sayı: 1, 0 - 0, 01.01.2005
https://doi.org/10.1501/Ashd_0000000057

Öz

Purpose: Afler convcntional doses of 55 10 65 Gy of fractionaled irradiation. anaplastic astrocytoma (AA) and gtiobla.s(on)a ınultitbrme (GBM) usually recur aı us orginal location. The preseni sludy was designcd lo deternıinc whclher hyperfraciionaıed radiolherapy (IIPRT) woııld improve local luınor control and patients' survival. Also Ihe factors effeeting thc prognosis in high gradc asirocyıoma weredetecicd.
Conciusion; Although we obscrved prolonged survival ın our study compared wiıh the convcntional radiothcrapy results in the literatüre, hard to say it is relaled lo HF'RT dııe to small number of patients. Our sludy gives an idca ihal HFRT can be easily applied and side effects are well toleraled.
Kcy Words: Radiolherapy; hyperfrac- lionated, malign asirocylomas.
Materials and Methods; Bclwecn Decemher 1994 and January 1996, 24 patients wcre cnrolled to a prospeclive study. Patients were hislologically confirmed wiıh AA and GBM and previously untreaıed. A total dose of 69.6 G)' was delivered in 1.2 Gy fraclions twice daily with an inter\'al of 6 to 8 hours. 5 days per week. Clinical Target Volüme (CT\0 was established as Gross Tumor Volüme (GTV) plu.s 2-2.5 cm and 05 cm was added xs safety margin for Pknning Target Volüme (PT\0-

Kaynakça

  • Ankara Üniversitesi – Ankara Sağlık Hizmetleri Dergisi - ASHD
Toplam 1 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Diğer
Yazarlar

Yıldız Güney Bu kişi benim

Yayımlanma Tarihi 1 Ocak 2005
Gönderilme Tarihi 1 Ocak 2005
Yayımlandığı Sayı Yıl 2005 Cilt: 7 Sayı: 1

Kaynak Göster

APA Güney, Y. (2005). Hyperfractionated Radiotherapy in Malignant Astrocytomas. Ankara Sağlık Hizmetleri Dergisi, 7(1). https://doi.org/10.1501/Ashd_0000000057
AMA Güney Y. Hyperfractionated Radiotherapy in Malignant Astrocytomas. ASHD. Ocak 2005;7(1). doi:10.1501/Ashd_0000000057
Chicago Güney, Yıldız. “Hyperfractionated Radiotherapy in Malignant Astrocytomas”. Ankara Sağlık Hizmetleri Dergisi 7, sy. 1 (Ocak 2005). https://doi.org/10.1501/Ashd_0000000057.
EndNote Güney Y (01 Ocak 2005) Hyperfractionated Radiotherapy in Malignant Astrocytomas. Ankara Sağlık Hizmetleri Dergisi 7 1
IEEE Y. Güney, “Hyperfractionated Radiotherapy in Malignant Astrocytomas”, ASHD, c. 7, sy. 1, 2005, doi: 10.1501/Ashd_0000000057.
ISNAD Güney, Yıldız. “Hyperfractionated Radiotherapy in Malignant Astrocytomas”. Ankara Sağlık Hizmetleri Dergisi 7/1 (Ocak 2005). https://doi.org/10.1501/Ashd_0000000057.
JAMA Güney Y. Hyperfractionated Radiotherapy in Malignant Astrocytomas. ASHD. 2005;7. doi:10.1501/Ashd_0000000057.
MLA Güney, Yıldız. “Hyperfractionated Radiotherapy in Malignant Astrocytomas”. Ankara Sağlık Hizmetleri Dergisi, c. 7, sy. 1, 2005, doi:10.1501/Ashd_0000000057.
Vancouver Güney Y. Hyperfractionated Radiotherapy in Malignant Astrocytomas. ASHD. 2005;7(1).